Rejuvenating Cells via Mitophagy to Address Unmet Medical Need

Time: 4:00 pm
day: Day One


  • Examining the benefits of mitophagy induction via Urolithin A on mitochondrial function were demonstrated across a broad range of models
  • A closer look at Vandria, a spin-off of Amazentis dedicated to the development of novel pharmaceuticals, possesses a growing pipeline of next generation small molecule mitophagy inducers
  • Evaluating results and target pharmaceutical applications of new chemical entities